Assignee profile:

Figene, LLC

City:

Houston, Texas

Country:

United States

Published Applications:

13

Last publication date:

2024-09-05

Patent Grants:

6

Last grant date:

2024-04-16

Top Inventors for applications by Figene, LLC

These are the the leading inventors for applications assigned to Figene, LLC:

Recent patent applications by Figene, LLC

Figene, LLC based in Houston, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-09-05
US20240293469A1
Human necessities

FIBROBLAST DELIVERY OF TUMOR INHIBITORY AGENTS

#2 | 2024-09-05
US20240293468A1
Human necessities

FIBROBLAST DELIVERY OF TUMOR INHIBITORY AGENTS

#3 | 2024-08-29
US20240287459A1
Chemistry; metallurgy

MEANS AND METHODS OF PREVENTING OR REVERSING AGING

#4 | 2024-08-15
US20240269193A1
Human necessities

STIMULATION OF ANGIOGENESIS BY FIBROBLAST DERIVED EXOSOMES

#5 | 2024-08-08
US20240263140A1
Chemistry; metallurgy

AUGMENTATION OF FIBROBLAST REGENERATIVE ACTIVITY

#6 | 2024-08-08
US20240261336A1
Human necessities

TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND LUNG DEGENERATION USING ACTIVATED FIBROBLASTS AND EXOSOME DERIVATIVES THEREOF

#7 | 2021-06-17 ✅ Patent 11,959,102 granted on 2024-04-16
US20210180020A1
Chemistry; metallurgy

Augmentation of fibroblast regenerative activity

#8 | 2021-03-18 ✅ Patent 11,732,239 granted on 2023-08-22
US20210079350A1
Chemistry; metallurgy

Treatment of disc degenerative disease and stimulation of proteoglycan synthesis by fibroblast conditioned media and formulations thereof

#9 | 2020-12-31
US20200405770A1
Human necessities

ADMINISTRATION OF FIBROBLASTS AND DERIVATIVES THEREOF FOR TREATMENT OF TYPE 2 DIABETES

#10 | 2020-12-03 ✅ Patent 11,878,037 granted on 2024-01-23
US20200376041A1
Human necessities

Concurrent activation of regenerative and tolerogenic processes by fibroblast-based compositions for the treatment of multiple sclerosis

#11 | 2020-10-29 ✅ Patent 12,310,991 granted on 2025-05-27
US20200338133A1
Human necessities

Stimulation of angiogenesis by fibroblast derived exosomes

#12 | 2020-09-24 ✅ Patent 11,975,030 granted on 2024-05-07
US20200297774A1
Human necessities

Treatment of chronic obstructive pulmonary disease and lung degeneration using activated fibroblasts and exosome derivatives thereof

#13 | 2016-08-04 ✅ Patent 11,819,555 granted on 2023-11-21
US20160220699A1
Human necessities

Gene therapy for the regeneration of chondrocytes or cartilage type cells

Also check out Figene, LLC's (Houston, United States) applicant profile with 11 patent applications submitted.

AssigneeID:

167091 ⎘